Pharmafile Logo

News and Press Releases

Mogrify appoints Dr Jonathan Appleby as chief scientific officer

Strategic hire bolsters executive leadership team as company progresses multiple therapeutic programmes toward and into clinical development 15 July 2024 – Cambridge, UK – Mogrify, a regenerative medicine company developing...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: July 15, 2024

Mogrify
info@mogrify.co.uk
25 Cambridge Science Park Milton Rd, Milton, Cambridge CB4 0FW

Deep Genomics Expands Executive Leadership and Operations in Latest Strategic Growth Initiative  

Company announces executive new hires and marks significant momentum with Cambridge, Massachusetts, US, site opening and Toronto, Canada, office expansion   13 June 2024 -- Massachusetts, US -- Deep Genomics, the...

Category: Biotechnology, Other, Pharmaceutical
Posted: June 13, 2024

Deep Genomics
press@deepgenomics.com
480 University Ave, Suite 1300 Toronto, Ontario, Canada, M5G 1V2

Biogen Receives European Commission Approval for QALSODY (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS

SOD1-ALS is a devastating, uniformly fatal and ultra-rare genetic form of ALS estimated to affect less than 1,000 people in Europe QALSODY is Biogen’s third rare disease therapy to be...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: May 30, 2024

Biogen
Biogen International GmbH Neuhofstrasse 30 6340 Baar Switzerland

First Study Using Biomimetic AI Digital Twins And Multiomics in Genetics Research

Paper on the ground-breaking research by Genzeva, LumaGene, RYLTI, Brigham & Women’s Hospital of Harvard University, and QIAGEN Digital Insights was published this week in the Journal of Molecular Diagnostics 3 April...

Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: April 3, 2024

GENZEVA
hello@genzeva.com
9420 Key West Avenue, Suite 100, Rockville, Maryland

TMC Pharma champions holistic approach to medical services in rare disease drug development

13 March 2024 – In a recent webinar, rare disease specialist and global clinical research organisation (CRO) TMC Pharma gathered esteemed speakers to share insights into the scope of medical...

Category: Drug Discovery, Pharmaceutical
Posted: March 13, 2024

TMC Pharma
info@tmcpharma.com
Lodge Farm Barn Elvetham Park Estate, Fleet Road, Hartley Wintney, Hampshire RG27 8AS, UK

Clinigen launches ‘What is Possible?’ campaign to accelerate access to medicines on Rare Disease Day 

With over 7,000 rare diseases that impact over 300 million people globally, just 5% of rare diseases have a licensed treatment 29 February 2024 -- London, UK -- Clinigen, the...

Category: Other
Posted: February 29, 2024

Clinigen
25 Bedford Square Bloomsbury London WC1B 3HH